EyePoint Pharmaceuticals (EYPT) Earnings Date, Estimates & Call Transcripts → A new way to collect income from stocks (From DTI) (Ad) Free eypt Stock Alerts $17.91 +0.96 (+5.66%) (As of 09:58 AM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateMay. 1EstimatedActual EPS (Mar. 7) -$0.33 Beat By $0.27 Consensus EPS (Mar. 7) -$0.60 Listen to Call Get EyePoint Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for EYPT and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueEYPT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.EYPT Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry EyePoint Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20241($0.36)($0.36)($0.36) Q2 20241($0.37)($0.37)($0.37) Q3 20241($0.38)($0.38)($0.38) Q4 20241($0.39)($0.39)($0.39) FY 20244($1.50)($1.50) ($1.50)EYPT Earnings Date and InformationEyePoint Pharmaceuticals last announced its quarterly earnings results on March 7th, 2024. The reported ($0.33) EPS for the quarter, topping the consensus estimate of ($0.60) by $0.27. The firm had revenue of $14.03 million for the quarter, compared to the consensus estimate of $8.71 million. EyePoint Pharmaceuticals has generated ($1.83) earnings per share over the last year (($1.83) diluted earnings per share). Earnings for EyePoint Pharmaceuticals are expected to decrease in the coming year, from ($1.73) to ($2.59) per share. EyePoint Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 1st, 2024 based off prior year's report dates.Read More EyePoint Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/1/2024Estimated)------- 3/7/2024Q4 2023($0.60)($0.33)+$0.27($0.33)$8.71 million$14.03 million 11/1/2023Q3 2023($0.62)($0.33)+$0.29($0.33)$3.90 million$15.20 million8/2/2023Q2 2023$0.41($0.61)($1.02)($0.61)$79.03 million$9.11 million 5/3/2023Q1 2023($0.65)($0.56)+$0.09($0.56)$7.50 million$7.68 million3/2/2023Q4 2022($0.63)($0.61)+$0.02($0.06)$9.71 million$10.53 million11/2/2022Q3 2022($0.70)($0.49)+$0.21($0.49)$10.06 million$10.01 million Get the Latest News and Ratings for EYPT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for EyePoint Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/3/2022Q2 2022($0.57)($0.52)+$0.05($0.52)$11.27 million$11.57 million5/4/2022Q1 2022($0.50)($0.52)($0.02)($0.48)$10.35 million$9.29 million 3/3/2022Q4 2021($0.50)($0.59)($0.09)($0.59)$9.75 million$11.19 million 11/3/2021Q3 2021($0.47)($0.58)($0.11)($0.58)$9.60 million$9.06 million 8/4/2021Q2 2021($0.45)($0.35)+$0.10($0.35)$8.80 million$9.01 million 5/5/2021Q1 2021($0.52)($0.50)+$0.02($0.50)$8.29 million$7.32 million EyePoint Pharmaceuticals Earnings - Frequently Asked Questions When is EyePoint Pharmaceuticals's earnings date? EyePoint Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 1st, 2024 based off last year's report dates. Learn more on EYPT's earnings history. Did EyePoint Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, EyePoint Pharmaceuticals (NASDAQ:EYPT) reported ($0.33) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.60) by $0.27. Learn more on analysts' earnings estimate vs. EYPT's actual earnings. How can I listen to EyePoint Pharmaceuticals's earnings conference call? The conference call for EyePoint Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How much revenue does EyePoint Pharmaceuticals generate each year? EyePoint Pharmaceuticals (NASDAQ:EYPT) has a recorded annual revenue of $46.02 million. How much profit does EyePoint Pharmaceuticals generate each year? EyePoint Pharmaceuticals (NASDAQ:EYPT) has a recorded net income of -$70.79 million. EYPT has generated -$1.83 earnings per share over the last four quarters. What is EyePoint Pharmaceuticals's EPS forecast for next year? EyePoint Pharmaceuticals's earnings are expected to decrease from ($1.73) per share to ($2.59) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Standard BioTools Earnings Date Cytek Biosciences Earnings Date Quanterix Earnings Date Pacific Biosciences of California Earnings Date Nautilus Biotechnology Earnings Date Harvard Bioscience Earnings Date Bionano Genomics Earnings Date Accelerate Diagnostics Earnings Date Olink Holding AB (publ) Earnings Date 10x Genomics Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Taiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted Applied Optoelectronics earnings dumper, pain now for gain later? This page (NASDAQ:EYPT) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishingtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EyePoint Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
